Skip to main content
Clinical Trials/NCT02726932
NCT02726932CompletedNot Applicable

Intra-abdominal View and Inflammatory Markers in Secondary Peritonitis - Correlation to Recovery

Helsinki University Central Hospital1 site in 1 country283 target enrollmentStarted: March 30, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
283
Locations
1
Primary Endpoint
Mortality

Study Overview

Brief Summary

The purpose of this study is to analyze the correlation between intra-abdominal view and patient recovery in secondary peritonitis, and to create a new classification based on these results. Additionally, a variety of inflammatory markers from blood samples will be collected in order to analyze their correlation with patient outcomes.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • adult patients > 18 years old
  • operated for complicated intra-abdominal infection

Exclusion Criteria

  • another diagnosis requiring ICU level care at the same time
  • acute pancreatitis
  • acute mesenteric ischaemia due to occlusion in superior mesenteric artery or vein
  • peritonitis due to timely diagnosed trauma
  • missing informed consent or inability to understand it

Outcomes

Primary Outcomes

Mortality

Time Frame: 90 days

Death within 90 days of primary operation for diffuse peritonitis

ICU admission

Time Frame: 90 days

Intensive Care Unit admission and length of ICU treatment

Reoperations

Time Frame: 90 days

Reoperations needed postoperatively

Complications

Time Frame: 90 days

Postoperative complications according to Clavien-Dindo classification

Length of hospitalization

Time Frame: 90 days

Days in hospital postoperatively

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Matti Tolonen

M.D.

Helsinki University Central Hospital

Study Sites (1)

Loading locations...

Similar Trials